| Attributes | Values |
|---|
| rdf:type
| |
| Description
| - Introduction: Acute promyelocytic leukemia (APL) is a relatively rare subtype of acute myeloid leukemia. It has become the best curable subtype of acute leukemias in adults due to the inclusion of all-trans-retinoic acid (ATRA) in the treatment. Despite the efficacy of ATRA, chemotherapy must be added in APL patients in order to maintain durable complete remission. However, chemotherapy administration is inevitably related to many complications, including the risk of secondary malignancies. T-lymphoblastic lymphoma (T-LBL) is an infrequent disease that belongs to highly aggressive lymphomas group. Case report: The authors describe a 25-year-old woman treated for APL in 2002 and developed precursor T-LBL five years later. Conclusion: Several cases of secondary acute lymphoblastic leukemias in ?cured? APL patients have been described, but probably no patient with secondary precursor T-LBL. Secondary malignancies has become one of the topics discussed (not only) in APL patients. It is apparently related to their excellent treatment outcomes and long-term survival. Better tailored treatment based on the relevant prognostic factors allowing chemotherapy reduction or omission in some patients is being necessary. Vývoj péče o nemocné s esenciální trombocytemií ? The treatment advances in patients with esential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin according to the registry data in 2007 The Czech registry of patients treated with anagrelide (Thromboreductine) has been conducted since 2005. The aim of the registry is to determine the clinical and laboratory profile of patients with subsequent analysis.
- Introduction: Acute promyelocytic leukemia (APL) is a relatively rare subtype of acute myeloid leukemia. It has become the best curable subtype of acute leukemias in adults due to the inclusion of all-trans-retinoic acid (ATRA) in the treatment. Despite the efficacy of ATRA, chemotherapy must be added in APL patients in order to maintain durable complete remission. However, chemotherapy administration is inevitably related to many complications, including the risk of secondary malignancies. T-lymphoblastic lymphoma (T-LBL) is an infrequent disease that belongs to highly aggressive lymphomas group. Case report: The authors describe a 25-year-old woman treated for APL in 2002 and developed precursor T-LBL five years later. Conclusion: Several cases of secondary acute lymphoblastic leukemias in ?cured? APL patients have been described, but probably no patient with secondary precursor T-LBL. Secondary malignancies has become one of the topics discussed (not only) in APL patients. It is apparently related to their excellent treatment outcomes and long-term survival. Better tailored treatment based on the relevant prognostic factors allowing chemotherapy reduction or omission in some patients is being necessary. Vývoj péče o nemocné s esenciální trombocytemií ? The treatment advances in patients with esential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin according to the registry data in 2007 The Czech registry of patients treated with anagrelide (Thromboreductine) has been conducted since 2005. The aim of the registry is to determine the clinical and laboratory profile of patients with subsequent analysis. (en)
|
| Title
| - Precursor T-lymphoblastic lymphoma in a patient after successful treatment of acute promyelocytic leukemia
- Precursor T-lymphoblastic lymphoma in a patient after successful treatment of acute promyelocytic leukemia (en)
|
| skos:prefLabel
| - Precursor T-lymphoblastic lymphoma in a patient after successful treatment of acute promyelocytic leukemia
- Precursor T-lymphoblastic lymphoma in a patient after successful treatment of acute promyelocytic leukemia (en)
|
| skos:notation
| - RIV/61989592:15110/09:10224437!RIV12-MSM-15110___
|
| http://linked.open...avai/riv/aktivita
| |
| http://linked.open...avai/riv/aktivity
| |
| http://linked.open...iv/cisloPeriodika
| |
| http://linked.open...vai/riv/dodaniDat
| |
| http://linked.open...aciTvurceVysledku
| - PAPAJÍK, Tomáš
- Hluší, Antonín
- Faber, Edgar
- INDRÁK, Karel
- Kučerová, Ladislava
- Jarošová, Marie
- Szotkowski, Tomáš
- Hubáček, Jaromír
- Pikalová, Zuzana
- Holzerová, Milena
|
| http://linked.open.../riv/druhVysledku
| |
| http://linked.open...iv/duvernostUdaju
| |
| http://linked.open...titaPredkladatele
| |
| http://linked.open...dnocenehoVysledku
| |
| http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/09:10224437
|
| http://linked.open...riv/jazykVysledku
| |
| http://linked.open.../riv/klicovaSlova
| - acute myeloid leukemia; T-lymphoblastic lymphoma (en)
|
| http://linked.open.../riv/klicoveSlovo
| |
| http://linked.open...odStatuVydavatele
| - CH - Švýcarská konfederace
|
| http://linked.open...ontrolniKodProRIV
| |
| http://linked.open...i/riv/nazevZdroje
| |
| http://linked.open...in/vavai/riv/obor
| |
| http://linked.open...ichTvurcuVysledku
| |
| http://linked.open...cetTvurcuVysledku
| |
| http://linked.open...UplatneniVysledku
| |
| http://linked.open...v/svazekPeriodika
| |
| http://linked.open...iv/tvurceVysledku
| - Faber, Edgar
- Hubáček, Jaromír
- Indrák, Karel
- Jarošová, Marie
- Pikalová, Zuzana
- Potomková, Jarmila
- Hluší, Antonín
- Kučerová, Ladislava
- Papajík, Tomáš
- Szotkowski, Tomáš
- Budíková, Miroslava
- Buriánková, E.
- Holzerová, Milena
- Plachý, Radek
- Szotkowská, Romana
- Klusová, N.
|
| issn
| |
| number of pages
| |
| http://localhost/t...ganizacniJednotka
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)